Atom Grants
Toggle Sidebar main
Eligibility
Profile
Finance
Other
Similar Grants
Platform
Discover
For You
Search
Favorites
Account
Profile
Research Interests
Atom | Innovation in Drug Research and Development for Highly Prevalent Chronic Diseases: An Action Collaborative
Back
Innovation in Drug Research and Development for Highly Prevalent Chronic Diseases: An Action Collaborative
Rolling Submissions
NASEM
Description
The goal of this collaborative is to examine and highlight the bottlenecks to drug research and development (R&D) for highly prevalent chronic diseases and develop a set of key considerations and potential strategies for spurring innovation. Collaborative participants will develop and distribute a structured, qualitative questionnaire to key stakeholders. Results will be synthesized and used to inform next steps for the collaborative. Half of all Americans live with at least one chronic disease, such as heart disease, cancer, st...
Read more
Eligible Applicants
- Unrestricted
Funding Type
other
Categories of Funding Activity
- Health and Medicine
Grantor Contact Information
Forum Staff: Drug Forum Officers Carolyn Shore, Bianca Espinosa, Deanna Giraldi, Kyle Cavagnini
Grantor Email
drugforum@nas.edu
Other Grantor Information
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide independent, objective advice to inform policy with evidence, spark progress and innovation, and confront challenging issues for the benefit of society. They are comprised of three academies: the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Medicine. The organization convenes hundreds of conferences, workshops, and symposia annually, bringing together leading experts from academia, public, and private sectors. Their work focuses on providing high-quality, evidence-based consensus on complex scientific, engineering, and health-related challenges. They produce peer-reviewed reports, publish scientific journals, and serve as a trusted source of expert advice for policymaking. The National Academies mobilize approximately 6,000 top experts each year who volunteer their time and knowledge to conduct policy studies, workshops, and other activities aimed at addressing critical issues facing the nation and world.
Additional Information
The collaborative aims to articulate the unique challenges in spurring early-stage R&D innovation for chronic diseases, consider cultural and financial incentives for development, and draw lessons from other disease areas. Additional URLs:
https://www.cdc.gov/chronicdisease/about/index.htm
https://www.rand.org/content/dam/rand/pubs/tools/TL200/TL221/RAND_TL221.pdf
https://www.cdc.gov/nchs/fastats/default.htm
Supporting Link
https://www.nationalacademies.org/our-work/innovation-in-drug-research-and-development-for-highly-prevalent-chronic-diseases-an-action-collaborative
Start finding grants with Atom for
$0 today
$30 Billed monthly after 7-day trial. Cancel anytime.
Personalized grant emails delivered weekly, right to your inbox.
AI powered search engine with both keyword and semantic search capabilities.
Grant filters to find the perfect funding opportunities.
Get Started
Similar Grants
Strategies to Better Align Investments in Innovations for Therapeutic Development with Disease Burden and Unmet Needs
Rolling Submissions
NASEM
Advancing the Science of Patient Input in Medical Product R&D: An Action Collaborative
Rolling Submissions
NASEM
Rare Neurological Diseases Action Collaborative
Rolling Submissions
NASEM